Abstract:The increasing prevalence of neurodegenerative diseases constitutes a significant challenge to public health systems globally. Consequently, the quest for efficacious preventive and therapeutic strategies has assumed center stage in public health discourse. Animal models serve as indispensable instruments in neurodegenerative disease research, offering foundational data that inform our understanding of the pathological mechanisms and contribute to the development of novel therapeutic paradigms. This manuscript delineates the methodologies for constructing animal models germane to prevalent neurodegenerative conditions such as Alzheimer’s Disease, Parkinson’s Disease, and Amyotrophic Lateral Sclerosis. The establishment of these models incorporates factors like genetic etiology, pathological signatures, and the temporal course of disease progression. Traditional techniques in model development frequently exhibit shortcomings in disease specificity, phenotypic stability, and alignment with the pathological evolution of human ailments. However, advancements in gene-editing technologies, notably CRISPR/Cas9, facilitate the emulation of human neurodegenerative disease pathologies with increased precision. This augments the relevance of animal models as instrumental tools in pharmaceutical development and the formulation of disease prevention strategies. In addition to conventional neurodegenerative animal models, the manuscript explores advancements in innovative models including chemical induction models, human brain tissue transplantation models, spontaneous models, and accelerated aging models. A focal point of the discourse is the transformative impact of gene-editing technologies on animal model development, with emphasis on the theoretical foundations and methodologies for creating polygenic breeding models and genetically diverse, gene-edited models. 1. Key gene-editing technologies applied in the domain of animal model creation encompass gene knock-in/knock-out, RNA interference (RNAi), and CRISPR/Cas9. Gene knock-in entails the integration of a target gene into a predetermined genomic location, while gene knock-out involves the excision of a specific gene, either entirely or partially. Both processes are predicated on homologous recombination, leveraging the innate capability of DNA molecules for homologous pairing and exchange to insert the target gene at precise chromosomal loci. 2. Complex human diseases frequently involve an array of genes or quantitative trait loci (QTL), each exerting a modest impact on the disease phenotype. When multiple QTLs are inherited, disease manifestation or predisposition may ensue. The advancement of mouse models for Alzheimer’s Disease epitomizes this intricate multi-gene or multi-locus modification process. As stronger genetic drivers and their combinations are identified, the selection and arrangement of divergent mouse strains can refine these models further. 3. The utility of genetically diverse gene-edited animal models lies in their ability to replicate human genetic variability by exploiting the phenotypic differences inherent in mice with assorted genetic backgrounds. The integration of gene-edited animal models into neurodegenerative disease research enhances our mechanistic understanding of these conditions. The manuscript elucidates emergent research avenues in gene-edited animal models, including the capabilities of polygenic models to emulate intricate disease states and the evolving role of comorbidity models. These tools are pivotal for a comprehensive understanding of disease pathogenesis, the elucidation of environmental and genetic interactions, the screening of pharmaceutical candidates, and the conception of innovative therapeutic interventions. Although existing models fail to capture the full complexity of human diseases, there is a rational expectation that ongoing technological innovations will ameliorate these limitations, thereby influencing the future trajectory of neurodegenerative disease research.

Nutritional management of the heart transplant recipient.

The crucial role of diverse animal models to investigate cochlear aging and hearing loss

Model Organisms: Grandeur in the Diversity of Aging Organisms

Clinical relevance of animal models in aging-related dementia research

Modeling complex age-related eye disease

[Importance of serum interleukin-6 as a mediator of systemic inflammation in patients with alpha-1 antitrypsin deficiency].

Changes in frontal-parietal activation and math skills performance following adaptive number sense training: Preliminary results from a pilot study

Experiments in macaque monkeys provide critical insights into age-associated changes in cognitive and sensory function

Sensory-specific impairment among older people. An investigation using both sensory thresholds and subjective measures across the five senses

Simultaneous assessment of cognitive function, circadian rhythm, and spontaneous activity in aging mice

Are cognitive researchers ignoring their senses? The problem of sensory deficit in cognitive aging research

Cellular Senescence: Mechanisms, Morphology, and Mouse Models

Current Animal Model Systems for Ovarian Aging Research

Small organism models for mode of action research on anti-ageing and nootropic herbs, foods, and formulations

The Establishment and Application of Animal Models for Neurodegenerative Diseases

Vascular Aging in Rodent Models: Contrasting Mechanisms Driving the Female and Male Vascular Senescence

Age-Related Differences in Perception and Coding of Attractive Odorants in Mice

Performance study of block ACK and reverse direction in IEEE 802.11n using a Markov chain model

Cross‐species signaling pathways analysis inspire animal model selections for drug screening and target prediction in vascular aging diseases

[Evaluation of the influence of change in heart rate on left ventricular diastolic function indices].

Professionalism and medical ethics in dermatology--2000.